2Ouriel K,Gray B,Clair DG,et al.Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis[J].J Vasc Interv Radiol,2000,11:295
3Comerota AJ,Aldrigge SC.Thrombolytic therapy for deep venous thrombosis:a clinical review[J].Can J Surg,1993,36:359
4Bjarnason H,Kruse JR,Asinger DA,et al.Iliofemoral deep venous thrombdsis:safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy[J].J Vasc Interv Radiol,1997,8:405
6Greenfield LJ,McCurdy JR,Brown PP,et al.A new intracaval filter permitting continued flow and resolution of embolision[J].Surgery,1973,599
二级参考文献7
1Mewissen MW,Seabrook GR,Meissner MH,et al.Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry[].Radiology.1999
2Ouriel K,Gray B,Clair DG,et al.Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis[].Journal of Vascular and Interventional Radiology.2000
3Comerota AJ,Aldridge SC.Thrombolytic therapy for deep venous thrombosis: a clinical review[].Canadian journal of Surgery.1993
4Shull KC,Nicolaides AN,Fernandes e Fernandes J,et al.Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration[].Archives of Surgery.1979
5Greenfield LJ,McCurdy JR,Brown PP,et al.A new intracaval filter permitting continued flow and resolution of embolision[].Journal of Surgery.1973
6Bjarnason H,Kruse JR,Asinger DA,et al.Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheterdirected thrombolytic therapy[].Journal of Vascular and Interventional Radiology.1997
7Meyerovitz MF.Drug variables in thrombolytic therapy(Review)[].Journal of Vascular and Interventional Radiology.1995
